SUBSCRIBE
SUBSCRIBE
News   Business

Neurosearch A/S Inks Development Deal with Eli Lilly and Company (JOBS)

February 17, 2009 | 
1 min read
COPENHAGEN, Feb 17 (Reuters) - NeuroSearch on Tuesday announced a three-year drug discovery and development deal with Eli Lilly and Co, sending the Danish biotech company's shares as much as 11 percent higher.
Alliances Europe
Eli Lilly and Company
MORE ON THIS TOPIC
Illustration of employer’s hand holding employee who was laid off to drop him out of office
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
June 30, 2025
 · 
1 min read
 · 
Tristan Manalac
Themis with sword and scales in cyberspace. Ai regulation, artificial intelligence and law issues concept. Vector illustration.
Legal
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force
June 27, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong